496 related articles for article (PubMed ID: 17877123)
21. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
Tkaczyk M; Owczarek D; Finke D; Nowicki M
Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
[TBL] [Abstract][Full Text] [Related]
22. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF; Brodeh J
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[TBL] [Abstract][Full Text] [Related]
23. [Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment].
Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Wierciński R; Winiecka W; Smółko M; Porowski T; Koput A; Janicka K
Pol Merkur Lekarski; 2003 Aug; 15(86):172-5. PubMed ID: 14648986
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
[TBL] [Abstract][Full Text] [Related]
26. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
[TBL] [Abstract][Full Text] [Related]
27. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
Saeed B; Ossman MI; Sheriff S
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporin in steroid-resistant nephrotic syndrome.
Adhikari M; Coovadia HM
S Afr Med J; 1994 Nov; 84(11):753-6. PubMed ID: 7495012
[TBL] [Abstract][Full Text] [Related]
30. [The treatment of children with idiopathic nephrotic syndrome using cyclosporin].
Donckerwolcke RA; Vande Walle JG
Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1770-4. PubMed ID: 1407127
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
Kumar NS; Singh AK; Mishra RN; Prakash J
J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
[TBL] [Abstract][Full Text] [Related]
32. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
[TBL] [Abstract][Full Text] [Related]
33. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
Chishti AS; Sorof JM; Brewer ED; Kale AS
Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F; Ahmad TM; Anwar S
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[TBL] [Abstract][Full Text] [Related]
35. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
Chábová V; Tesar V; Zabka J; Rychlík I; Merta M; Jirsa M; Stejskalová A; Stejskal J
Cas Lek Cesk; 1996 Dec; 135(24):803-6. PubMed ID: 9072300
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors.
Wasilewska AM; Zoch-Zwierz WM
Pediatr Nephrol; 2004 Dec; 19(12):1349-53. PubMed ID: 15490252
[TBL] [Abstract][Full Text] [Related]
37. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
Ulinski T; Dubourg L; Saïd MH; Parchoux B; Ranchin B; Cochat P
Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
[TBL] [Abstract][Full Text] [Related]
38. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
Wyszyńska T; Ksiazek J; Wieteska-Klimczak A; Gorzkowska-Paczwa M; Dorywalski T; Tysarowska A
Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
[TBL] [Abstract][Full Text] [Related]
40. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'?
Doe JY; Funk M; Mengel M; Doehring E; Ehrich JH
Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]